Nyrada Inc – Annual Report

“Our lead brain injury program candidate, NYR-BI03, is targeting a very large and growing market. There are no current FDA-approved therapies for TBI which is experienced by over 70 million people worldwide each year. The estimated annual healthcare cost of non-fatal TBIs is over US$40 billion in the US alone.”